个性化文献订阅>期刊> Oncogene
 

Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases

  作者 Papagiannakopoulos, T; Friedmann-Morvinski, D; Neveu, P; Dugas, JC; Gill, RM; Huillard, E; Liu, C; Zong, H; Rowitch, DH; Barres, BA; Verma, IM; Kosik, KS  
  选自 期刊  Oncogene;  卷期  2012年31-15;  页码  1884-1895  
  关联知识点  
 

[摘要]MicroRNAs (miRNAs) carry out post-transcriptional control of a multitude of cellular processes. Aberrant expression of miRNA can lead to diseases, including cancer. Gliomas are aggressive brain tumors that are thought to arise from transformed glioma-initiating neural stem cells (giNSCs). With the use of giNSCs and human glioblastoma cells, we investigated the function of miRNAs in gliomas. We identified pro-neuronal miR-128 as a candidate glioma tumor suppressor miRNA. Decreased expression of miR-128 correlates with aggressive human glioma subtypes. With a combination of molecular, cellular and in vivo approaches, we characterize miR-128's tumor suppressive role. miR-128 represses giNSC growth by enhancing neuronal differentiation. miR-128 represses growth and mediates differentiation by targeting oncogenic receptor tyrosine kinases (RTKs) epithelial growth factor receptor and platelet-derived growth factor receptor-alpha. Using an autochthonous glioma mouse model, we demonstrated that miR-128 repressed gliomagenesis. We identified miR-128 as a glioma tumor suppressor that targets RTK signaling to repress giNSC self-renewal and enhance differentiation. Oncogene (2012) 31, 1884-1895; doi:10.1038/onc.2011.380; published online 29 August 2011

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内